Skip to content
The Policy VaultThe Policy Vault

Qbrexza (glycopyrronium) — Point32Health

primary axillary hyperhidrosis

Initial criteria

  • For patients age 9–17 years: Patient age ≥ 9 years AND documented diagnosis of primary axillary hyperhidrosis AND trial and failure with an aluminum chloride containing antiperspirant
  • For patients age ≥ 18 years: Documented diagnosis of primary axillary hyperhidrosis AND trial and failure with an aluminum chloride containing antiperspirant AND trial and failure with Botox